收藏切换
In vivo toxicokinetics of harmine and derivatives H-2-104 in rats
收藏切换
PDF
Bei CHEN1, 2, Shao-quan XU3, Chang-zhou WANG3, Bao-yu ZHAO3, Zhi-gao CHAI3, .ahelbk Bayan3, Peng-yu ZHU3, Li ZHANG4, Jun ZHAO1, 2, Qin MA5, Hui-jing GAO1, 2
Chinese Journal of New Drugs | 2023, 32(21) : 2178 - 2183
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(21): 2178-2183
In vivo toxicokinetics of harmine and derivatives H-2-104 in rats
Full
Bei CHEN1, 2, Shao-quan XU3, Chang-zhou WANG3, Bao-yu ZHAO3, Zhi-gao CHAI3, .ahelbk Bayan3, Peng-yu ZHU3, Li ZHANG4, Jun ZHAO1, 2, Qin MA5, Hui-jing GAO1, 2
Affiliations
  • 1Department of Pharmacy, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • 2State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Urumqi 830054, China
  • 3College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi 830054, China
  • 4Department of Pharmacy, the Affiliated Tumor Hospital of Medical University, Urumqi 830011, China
  • 5Xinjiang Huashidan Pharmaceutical Co., Ltd., Urumqi 830011, China
Published: 2023-11-15
Outline
收藏切换
Objectives:

HPLC was used to establish the methods for the determination of harmaline (HM) and the derivative 9-butyl-1-methyl-N-(2-hydroxy) ethyl-β- carboline-3-formamide (No.: H-2-104) in rat blood samples in order to evaluate repeated dosing toxicokinetics (TK).

Methods:

The Wistar rats were randomly divided into HM low, medium, and high-dose groups and H-2-104 low, medium, and high-dose groups (35, 70, 140 mg·kg-1) with eight rats in each group. Repeated dosing toxicity experiments were conducted to investigate the toxicokinetic profile of HM and H-2-104 in rats 28 days after the first dose to the end of administration and the kinetic parameters were calculated.

Results:

Both HM and derivative H-2-104 could be detected with good linearity in the range of 66.67~500 ng·mL-1. The specialized properties, accuracy, precision, extraction recovery, and stability of the proposed method were in accordance with the requirements for the determination of biological samples. After the administration of HM, the Cmax and AUC0-t in rats were (301.78±67.24) ng·mL-1, (234.18±98.35) ng·mL-1 (low concentration); (478.65±99.74) ng·mL-1, (710.03±208.93) ng·mL-1 (medium concentration); (721.51±107.52) ng·mL-1, (819.61±310.54) ng·mL-1 (high concentration). After the administration of H-2-104, the Cmax and AUC0-t in rats were (234.84±102.03) ng·mL-1, (198.67±38.88) ng·mL-1 (low concentration); (298.73±87.52), (676.55±210.83) ng·mL-1 (medium concentration); (411.81±123.71), (1 004.86±426.05) ng·mL-1 (high concentration). After administration, Tmax of the two compounds was shorter and both drugs were eliminated within 4 hours.

Conclusion:

The first and last Cmax and AUC0-t of HM and derivative H-2-104 at each dose increased disproportionately with dose and were positively correlated with dose, exhibiting nonlinear kinetics. This study provides preliminary elucidation of the in vivo toxicokinetic behavior of HM and derivative H-2-104 in rats, and the experimental results provide support and reference for their subsequent studies.

harmaline  /  derivatives H-2-104  /  HPLC  /  toxicokinetics  /  repeated administration
Bei CHEN, Shao-quan XU, Chang-zhou WANG, Bao-yu ZHAO, Zhi-gao CHAI, .ahelbk Bayan, Peng-yu ZHU, Li ZHANG, Jun ZHAO, Qin MA, Hui-jing GAO. In vivo toxicokinetics of harmine and derivatives H-2-104 in rats[J]. Chinese Journal of New Drugs, 2023 , 32 (21) : 2178 -2183 .
Year 2023 volume 32 Issue 21
PDF
33
13
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-11-15
Article Data
Affiliations
History
  • Accepted:2023-03-20
Funding
Affiliations
    1Department of Pharmacy, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    2State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Urumqi 830054, China
    3College of Pharmaceutical Sciences, Xinjiang Medical University, Urumqi 830054, China
    4Department of Pharmacy, the Affiliated Tumor Hospital of Medical University, Urumqi 830011, China
    5Xinjiang Huashidan Pharmaceutical Co., Ltd., Urumqi 830011, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT